Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Efavirenz-Based Regimen in HIV
NCT00135382Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2002
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of efavirenz in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Jun 2002; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00135382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135382.